Long-term follow up after successful discontinuation of prostacyclin analogues in patients with pulmonary arterial hypertension (PAH)

被引:0
|
作者
Zavala, EDG [1 ]
Minai, O [1 ]
Bair, N [1 ]
Banjac, S [1 ]
Arroliga, A [1 ]
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
D O I
10.1378/chest.128.4_MeetingAbstracts.161S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:161S / 161S
页数:1
相关论文
共 50 条
  • [1] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [2] DISCONTINUATION OF CHRONIC-HEMODIALYSIS AFTER CONTROL OF ARTERIAL-HYPERTENSION - LONG-TERM FOLLOW-UP
    WAUTERS, JP
    BRUNNER, HR
    KIDNEY INTERNATIONAL, 1983, 23 (03) : 549 - 549
  • [3] DISCONTINUATION OF CHRONIC-HEMODIALYSIS AFTER CONTROL OF ARTERIAL-HYPERTENSION - LONG-TERM FOLLOW-UP
    WAUTERS, JP
    BRUNNER, HR
    PROCEEDINGS OF THE EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION, 1982, 19 : 182 - 187
  • [4] Late Breaking Abstract - A long-term follow-up (LTFU) study of sotatercept for pulmonary arterial hypertension (PAH)
    Preston, Ioana R.
    Badesch, David
    Ghofrani, Hossein-Ardeschir
    Gibbs, J. Simon R.
    Gomberg-Maitland, Mardi
    Hoeper, Marius M.
    Humbert, Marc
    Mclaughlin, Vallerie V.
    Waxman, Aaron B.
    Manimaran, Solaiappan
    Mikhailova, Elina
    Pena, Janethe De Oliveira
    De Souza, Rogerio
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [7] Combination Therapy For Pulmonary Arterial Hypertension With Oral Treprostinil: Long-Term Follow Up
    Ruggiero, R. M.
    Bartolome, S.
    Chin, K. M.
    Torres, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [8] Predicting mortality during long-term follow-up in pulmonary arterial hypertension
    Kylhammar, David
    Hjalmarsson, Clara
    Hesselstrand, Roger
    Jansson, Kjell
    Kavianipour, Mohammad
    Kjellstrom, Barbro
    Nisell, Magnus
    Soderberg, Stefan
    Radegran, Goran
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [9] TRIUMPH 1: Long-Term Safety and Efficacy of Inhaled Treprostinil Sodium in Patients with Pulmonary Arterial Hypertension (PAH) - Two Year Follow-Up.
    Benza, R.
    Rubin, L.
    McLaughlin, V.
    Channick, R.
    Voswinckel, R.
    Tapson, V.
    Robbins, I.
    Olschewski, H.
    Seeger, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [10] Long-term follow-up of patients with arterial hypertension and ischemic stroke
    Simonenko, V. B.
    Shirokov, E. A.
    Ovchinnikov, Yu. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (03): : 16 - 23